Socialblood, which wants to set up a mobile network of blood donors, has become part of Facebook’s Internet.org initiative. It mentioned the partnership as part of a company statement on its Indiegogo campaign, which it kicked off last week. The goal is to improve blood donation in developing countries.
The goal of Internet.org is to make Internet access affordable in communities around the world. Its app provides free basic services in markets where internet access is less affordable. It allows people to browse selected health, employment and local information websites without data charges.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
A World Health Organization report noted that 75 low- and middle-income countries say they collect fewer than 10 donations per 1,000 members of the population.
Socialblood seeks to boost the number of voluntary donations through a social networking platform where the users use their social reach and influence to help meet the demand for blood, according to its Indiegogo web page. The idea is to make it easier for hospitals, blood banks and other organizations to recruit and manage donors more easily.
Karthik Naralasetty founded the company four years ago. Within the past year it took part in Tiger Labs’ healthcare accelerator.
Facebook has been increasingly interested in the healthcare space, particularly through the development of patient communities.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
